1. Inhibition of DNA‑PK by gefitinib causes synergism between gefitinib and cisplatin in NSCLC
   Chi Pan et al, 2020, International Journal of Oncology CrossRef
2. First-line pemetrexed and carboplatin plus anlotinib for epidermal growth factor receptor wild-type and anaplastic lymphoma kinase-negative lung adenocarcinoma with brain metastasis
   Chu Zhang et al, 2020, Medicine CrossRef
3. Oral Targeted Therapies and Central Nervous System (CNS) Metastases
   Michael P. Gabay et al, 2015, CNS Drugs CrossRef